Article Contents ::
- 1 Details About Generic Salt :: Balsalaz
- 2 Main Medicine Class:: Intestinal anti-inflammatory
- 3 Colazal Class: Intestinal anti-inflammatory
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Balsalaz
Main Medicine Class:: Intestinal anti-inflammatory
Colazal
Class: Intestinal anti-inflammatory
Drugs Class ::
Action Reduces inflammation of colon by preventing local production of substances involved in inflammatory process such as arachidonic acid.
Indications for Drugs ::
Indications Treatment of mildly to moderately active ulcerative colitis.
Drug Dose ::
Route/Dosage
ADULTS: PO 2.25 g (ie, three 750 mg capsules) tid (ie, 6.75 g/day) for 8 wk; some patients may require up to 12 wk of treatment.
Contraindication ::
Contraindications Hypersensitivity to salicylates or any of the components of balsalazide capsules or balsalazide metabolites.
Drug Precautions ::
Precautions
Pregnancy: Category B. Lactation: Undetermined. Children: Safety and efficacy not established. Colitis exacerbation: Some patients may develop symptoms of colitis.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CNS: Headache; insomnia; dizziness. EENT: Rhinitis; pharyngitis; coughing; sinusitis. GI: Abdominal pain; nausea; vomiting; rectal bleeding; flatulence; dyspepsia; anorexia; frequent stools; dry mouth; cramps; constipation. GU: Urinary tract disorder. HEPA: Hepatotoxicity; jaundice; cholestatic jaundice; cirrhosis; hepatocellular damage. RESP: Respiratory disorder; infection. OTHER: Arthralgia; fatigue; fever; pain; back pain; myalgia; flu-like symptoms.
Drug Mode of Action ::
Action Reduces inflammation of colon by preventing local production of substances involved in inflammatory process such as arachidonic acid.
Drug Interactions ::
Interactions None well documented.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note history of pyloric stenosis.
- Monitor patient for GI, CNS, and musculoskeletal side effects and report to physician if noted and significant.
- Assess patient’s colitis symptoms including the following: rectal bleeding, stool frequency and character, abdominal pain, and overall functional status.
- Store at controlled room temperature.
Drug Storage/Management ::
Administration/Storage
- Do not chew or crush. Instruct patient to swallow capsule whole.
- Give tid with a full glass of water.
- Store at controlled room temperature.
Drug Notes ::
Patient/Family Education
- Explain name, dose, action, and potential side effects of drug.
- Advise patient to not crush or chew medication and to swallow the capsule whole with a full glass of water.
- Advise patient that usual course of therapy is 8 to 12 wk.
- Advise patient to report worsening of colitis symptoms to physician.
- Advise patients to inform the health care provider if experiencing side effects such as headache, stomach pain, nausea, or diarrhea.
- Advise patients that follow-up visits and examinations may be required to monitor therapy; remind patients to keep appointments.